[1]
Nguyen, T.D. et al. 2025. PREVALENCE OF NON-ALBUMINURIC CKD, ASSOCIATED FACTORS, AND TREATMENT OUTCOMES WITH DAPAGLIFLOZIN COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL. Cantho Journal of Medicine and Pharmacy. 85 (Mar. 2025), 36–42. DOI:https://doi.org/10.58490/ctump.2025i85.3583.